SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme eyes inorganic growth through acquisitions

20 Jun 2017 Evaluate

Advanced Enzyme Technologies is eyeing inorganic growth through acquisitions and targeting Rs 1,000 crore turnover in the next five years. The company is looking for acquisitions in Europe and North America. The company has repaid the debt of around Rs 120 crore in the last two years and it is generating cash, which will be used to fund the acquisition plans.

Advanced Enzyme Technologies is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.


Advanced Enzyme Tech Share Price

324.40 6.35 (2.00%)
09-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1938.85
Dr. Reddys Labs. 1269.80
Cipla 1441.70
Zydus Lifesciences 1159.85
Lupin 2502.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: